Effects of weight reduction and angiotensin-converting enzyme inhibition on IgA nephropathy-associated proteinuria.
J J
JJ
Kuiper
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D004038:Diet, Reducing; D005260:Female; D005922:Glomerulonephritis, IGA / Q000503:physiopathology / Q000628:therapy* / Q000652:urine; D006417:Hematuria; D006801:Humans; D017706:Lisinopril / Q000627:therapeutic use*; D008148:Lovastatin / Q000627:therapeutic use; D008875:Middle Aged; D009765:Obesity; D011507:Proteinuria; D015431:Weight Loss
D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D002784:Cholesterol; D008148:Lovastatin; D017706:Lisinopril